Figure 4
Figure 4. Comparison of outcomes according to MRD achievement after HCR. (A) HRFS based on whether MR3 was achieved at 3 months after HCR. (B) HRFS based on whether MR5 was achieved at 3 months after HCR. (C) HRFS for subjects that did not receive allo-HCT, based on whether they achieved MR5 at 3 months after HCR. (D) HRFS for allo-HCT recipients, based on whether they achieved MR3 just before allo-HCT. (E) HRFS for allo-HCT recipients, based on whether they achieved MR5 just before allo-HCT. (F) HRFS for allo-HCT recipients, based on whether they had maintained MR5 at 3 months after allo-HCT; the group that failed to maintain MR5 included subjects that had relapsed (MRD positive) and those that had failed to achieve MR5.

Comparison of outcomes according to MRD achievement after HCR. (A) HRFS based on whether MR3 was achieved at 3 months after HCR. (B) HRFS based on whether MR5 was achieved at 3 months after HCR. (C) HRFS for subjects that did not receive allo-HCT, based on whether they achieved MR5 at 3 months after HCR. (D) HRFS for allo-HCT recipients, based on whether they achieved MR3 just before allo-HCT. (E) HRFS for allo-HCT recipients, based on whether they achieved MR5 just before allo-HCT. (F) HRFS for allo-HCT recipients, based on whether they had maintained MR5 at 3 months after allo-HCT; the group that failed to maintain MR5 included subjects that had relapsed (MRD positive) and those that had failed to achieve MR5.

Close Modal

or Create an Account

Close Modal
Close Modal